Vienna, Austria

Günther Adolf

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Oncology: The Contributions of Inventor Günther Adolf

Introduction: Günther Adolf, a renowned inventor based in Vienna, Austria, has made significant strides in the field of oncology. His inventive spirit has culminated in a pivotal patent that focuses on the development of specialized antibodies. This invention not only holds potential for medical advancements but also showcases the intersection of research and practical application in the fight against cancer.

Latest Patents: Günther Adolf boasts one notable patent: "Antibodies specific for CD44v6." This groundbreaking invention pertains to antibodies that are specifically targeted at an epitope encoded by the variant exon v6 of the CD44 gene. This patent also encompasses nucleic acid molecules that encode the antibody proteins, methods for producing these proteins, and pharmaceutical compositions containing them. The broader implications of this invention lie in its potential use for manufacturing medicaments in the treatment of cancer, marking a significant advancement in therapeutic options available to patients.

Career Highlights: Adolf has built his career with a focus on innovative pharmaceutical solutions. Notably, he has worked with Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH, where he contributed to advancements in drug development and research. His experience in these prestigious companies further highlights his dedication and expertise in the field of pharmaceuticals and biomedicine.

Collaborations: Throughout his career, Günther Adolf has collaborated with several notable professionals, including Elinborg Ostermann and Erik Patzelt. These collaborations have contributed to the enriched research environment that fosters innovation and the development of impactful medical solutions.

Conclusion: In summary, Günther Adolf's contributions to oncology through his patent on antibodies specific for CD44v6 present a vivid illustration of how scientific research translates into potential therapeutic applications. His career and partnerships not only advance the frontier of cancer treatment but also inspire future innovations in the field. As the landscape of medicine evolves, the significance of such inventions is bound to grow, offering hope and solutions for those affected by cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…